Abstract
The obesity epidemic has transformed children's healthcare, such that diabetes, hypertension and the metabolic syndrome are phrases more commonly used by child health providers than ever before. This article reviews the economic consequences of this epidemic for healthcare delivery systems, both in the short term when obesity has been associated with increased utilization, and in the long term where increased likelihood of adult obesity and cardiovascular disease is well documented. Large investments through research and prevention are needed and are likely to provide strong returns in cost savings, and would optimally emerge through a cooperative effort between private and government payers alike.
Original language | English (US) |
---|---|
Pages (from-to) | 39-45 |
Number of pages | 7 |
Journal | Expert Review of Pharmacoeconomics and Outcomes Research |
Volume | 12 |
Issue number | 1 |
DOIs | |
State | Published - Feb 2012 |
Keywords
- cardiovascular disease
- economic costs
- healthcare utilization
- obesity
ASJC Scopus subject areas
- Health Policy
- Pharmacology (medical)